- Ukwelashwa
- Ubufakazi
- I-Neuroblastoma
- Isimila Esiqinile
- Ubufakazi
- I-TILS
- Ukwelashwa Kwamaseli e-NK
- I-Myasthenia Gravis (MG)
- I-Acute Lymphoblastic Leukemia (B-ALL)
- I-Systemic Lupus Erythematosus (SLE)
- I-Acute Lymphoblastic Leukemia (T-ALL)
- I-Non-Hodgkin Lymphoma (NHL)
- I-Multiple Myeloma (MM)
- I-Diffuse Large B-cell Lymphom
- I-B-lymphocytic Leukemia
- I-Myeloma
Umdlavuza wamaphaphu ongewona amangqamuzana amancane (i-NSCLC)-02
Isiguli sesilisa esineminyaka engu-82 ubudala saqala ukubonakala ekuqaleni kukaMashi 2023 sinobuthakathaka obuqhubekayo, ukulahlekelwa yisifiso sokudla, kanye nokwehla kwesisindo okungamakhilogremu angu-5. Lapho singeniswa esibhedlela, kwenziwa ukuhlolwa okuningiliziwe. I-CT scan yesifuba yembule amaqhubu amaningi kuwo womabili amaphaphu, elikhulu kunawo wonke lingama-2.5 cm. Iqhubu elikhulu kunawo wonke engxenyeni ye-apical ye-lobe engezansi kwesokudla kanye neqhubu elikhulu kunawo wonke engxenyeni ye-dorsal ye-lobe engenhla kwesobunxele zombili zazinemingcele engacacile. Ngemva kokuhlolwa kwe-biopsy yesifuba kanye nokuhlolwa kwe-pathological, kwaqinisekiswa ukuxilongwa komdlavuza wamaphaphu ongewona amaseli amancane (i-NSCLC), lapho i-adenocarcinoma ikhona engxenyeni ye-dorsal ye-lobe engenhla kwesobunxele kanye nengxenye ye-apical ye-lobe engezansi kwesokudla.
Ngemva kwalokho isiguli sathola uhlelo lokwelashwa nge-immunotherapy yamaseli e-NK. Ngemva kwenyanga yokuqala yokwelashwa, ukuhlolwa okulandelayo akubonisanga ushintsho olukhulu ngobukhulu bamaqhubu emaphashini, kodwa izimpawu zesiguli sezizonke zase zithuthukile, kanye nobuthakathaka obunciphile kanye nokubuyela kancane kancane kwesifiso sokudla. Ngemva kwenyanga yesibili yokwelashwa, esinye i-CT scan yesifuba sabonisa umkhawulo ocacile kanye nokwehla okuncane kosayizi weqhubu engxenyeni ye-apical ye-lobe engezansi yesokudla, kanye ne-necrosis engaphelele enohlaka olucacile lweqhubu engxenyeni yangemuva ye-lobe engenhla kwesobunxele. Ngemva kwenyanga yesithathu yokwelashwa, i-CT yesifuba yabonisa ukwehla okwengeziwe kosayizi wamaqhubu emaphashini womabili, lapho iqhubu elikhulu manje lingadluli ku-1.5 cm, ukumuncwa okuthile kwezilonda zamaphaphu, kanye nokuthuthuka okuphawulekayo kwezokwelapha.
Ngamafuphi, ukwelashwa nge-NK cell immunotherapy kubonise ukusebenza kahle nokubekezeleleka okuhle kulesi siguli sesilisa esineminyaka engu-82 ubudala esine-NSCLC, kanye nokwehla okukhulu kwezilonda zamaphaphu kanye nokuthuthuka okukhulu esimweni sonke sesiguli. Izinhlelo zokulandelela kanye nokwelashwa okwengeziwe kuzoqhubeka nokuqapha ukuqhubeka kwesifo kanye nemiphumela yokwelashwa.
incazelo2